Table of Content
Table of Content
1 Drug Repurposing Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Drug Repurposing
1.3 Drug Repurposing Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Drug Repurposing Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Drug Repurposing
1.4.2 Applications of Drug Repurposing
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Drug Repurposing Industry Trends
1.5.2 Drug Repurposing Drivers
1.5.3 Drug Repurposing Market Challenges
1.5.4 Drug Repurposing Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Drug Repurposing Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Drug Repurposing Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Drug Repurposing Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Drug Repurposing
2.2.1 Major Players Manufacturing Base of Drug Repurposing in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Drug Repurposing Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Drug Repurposing
2.3.3 Labor Cost of Drug Repurposing
2.4 Market Channel Analysis of Drug Repurposing
2.5 Major Down Stream Customers by Application
3 Global Drug Repurposing Market, by Type
3.1 Global Drug Repurposing Revenue and Market Share by Type (2018-2021)
3.2 Global Drug Repurposing Production and Market Share by Type (2018-2021)
3.3 Global Drug Repurposing Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Drug Repurposing Revenue and Growth Rate of Orally Drug
3.3.2 Global Drug Repurposing Revenue and Growth Rate of Intravenously Drug
3.4 Global Drug Repurposing Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Drug Repurposing Market, by Application
4.1 Downstream Market Overview
4.2 Global Drug Repurposing Consumption and Market Share by Application (2018-2021)
4.3 Global Drug Repurposing Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Drug Repurposing Consumption and Growth Rate of Central Nervous Disorders (2018-2021)
4.3.2 Global Drug Repurposing Consumption and Growth Rate of Cardiovascular Disorders (2018-2021)
4.3.3 Global Drug Repurposing Consumption and Growth Rate of Oncology (2018-2021)
4.3.4 Global Drug Repurposing Consumption and Growth Rate of Metabolic (2018-2021)
4.3.5 Global Drug Repurposing Consumption and Growth Rate of Autoimmune (2018-2021)
4.3.6 Global Drug Repurposing Consumption and Growth Rate of Other (2018-2021)
5 Global Drug Repurposing Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Drug Repurposing Revenue and Market Share by Region (2018-2021)
5.2 Global Drug Repurposing Consumption and Market Share by Region (2018-2021)
5.3 Global Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Drug Repurposing Market Under COVID-19
5.4.2 North America Drug Repurposing SWOT Analysis
5.5 Europe Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Drug Repurposing Market Under COVID-19
5.5.2 Europe Drug Repurposing SWOT Analysis
5.6 China Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Drug Repurposing Market Under COVID-19
5.6.2 China Drug Repurposing SWOT Analysis
5.7 Japan Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Drug Repurposing Market Under COVID-19
5.7.2 Japan Drug Repurposing SWOT Analysis
5.8 Middle East and Africa Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Drug Repurposing Market Under COVID-19
5.8.2 Middle East and Africa Drug Repurposing SWOT Analysis
5.9 India Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Drug Repurposing Market Under COVID-19
5.9.2 India Drug Repurposing SWOT Analysis
5.10 South America Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Drug Repurposing Market Under COVID-19
5.10.2 South America Drug Repurposing SWOT Analysis
5.11 South Korea Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Drug Repurposing Market Under COVID-19
5.11.2 South Korea Drug Repurposing SWOT Analysis
5.12 Southeast Asia Drug Repurposing Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Drug Repurposing Market Under COVID-19
5.12.2 Southeast Asia Drug Repurposing SWOT Analysis
6 Global Drug Repurposing Production by Top Regions (2018-2021)
6.1 Global Drug Repurposing Production by Top Regions (2018-2021)
6.2 North America Drug Repurposing Production and Growth Rate
6.3 Europe Drug Repurposing Production and Growth Rate
6.4 China Drug Repurposing Production and Growth Rate
6.5 Japan Drug Repurposing Production and Growth Rate
6.6 India Drug Repurposing Production and Growth Rate
7 Global Drug Repurposing Consumption by Regions (2018-2021)
7.1 Global Drug Repurposing Consumption by Regions (2018-2021)
7.2 North America Drug Repurposing Consumption and Growth Rate
7.3 Europe Drug Repurposing Consumption and Growth Rate
7.4 China Drug Repurposing Consumption and Growth Rate
7.5 Japan Drug Repurposing Consumption and Growth Rate
7.6 Middle East & Africa Drug Repurposing Consumption and Growth Rate
7.7 India Drug Repurposing Consumption and Growth Rate
7.8 South America Drug Repurposing Consumption and Growth Rate
7.9 South Korea Drug Repurposing Consumption and Growth Rate
7.10 Southeast Asia Drug Repurposing Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Mylan Inc. Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Drug Repurposing Product Profiles, Application and Specification
8.2.3 Mylan Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Johnson & Johnson Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Drug Repurposing Product Profiles, Application and Specification
8.3.3 Johnson & Johnson Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Abbott Healthcare Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Drug Repurposing Product Profiles, Application and Specification
8.4.3 Abbott Healthcare Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Sandoz Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Drug Repurposing Product Profiles, Application and Specification
8.5.3 Sandoz Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 IBM Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Drug Repurposing Product Profiles, Application and Specification
8.6.3 IBM Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Novartis AG Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Drug Repurposing Product Profiles, Application and Specification
8.7.3 Novartis AG Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Teva Pharmaceuticals Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Drug Repurposing Product Profiles, Application and Specification
8.8.3 Teva Pharmaceuticals Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Pfizer Inc. Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Drug Repurposing Product Profiles, Application and Specification
8.9.3 Pfizer Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Hoffmann-La Roche Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Drug Repurposing Product Profiles, Application and Specification
8.10.3 Hoffmann-La Roche Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Drug Repurposing Market Analysis and Forecast by Type and Application
9.1 Global Drug Repurposing Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Orally Drug Market Revenue and Volume Forecast (2021-2026)
9.1.2 Intravenously Drug Market Revenue and Volume Forecast (2021-2026)
9.2 Global Drug Repurposing Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Central Nervous Disorders Market Revenue and Volume Forecast (2021-2026)
9.2.2 Cardiovascular Disorders Market Revenue and Volume Forecast (2021-2026)
9.2.3 Oncology Market Revenue and Volume Forecast (2021-2026)
9.2.4 Metabolic Market Revenue and Volume Forecast (2021-2026)
9.2.5 Autoimmune Market Revenue and Volume Forecast (2021-2026)
9.2.6 Other Market Revenue and Volume Forecast (2021-2026)
10 Drug Repurposing Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Drug Repurposing Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
